Weak retail sales and falls in key oil and drug stocks stifle FTSE 100 - The FTSE 100 index closed down 17.15 points, 0.2%, ...

In a first for the bloc, Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended marketing ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted UK pharma major GSK’s regulatory application to expand the ...

Cuts to federal research funding may delay a potential hepatitis B cure, as trials led by UCSF progress. Asian Americans ...

GSK PLC closed 16.45% below its 52-week high of £16.79, which the company reached on September 9th.

GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Patient-reported outcomes from the OUTBACK trial highlight common, persistent sexual side effects that should be addressed following cervical cancer treatment.

Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

PE Hub has rounded up six deals going back to early January involving companies in the oncology segment, starting with the ...